Clin2
NCT07422506Possibly a fitRecruiting

Comparing treatments for early missed abortion

Missed AbortionEarly Pregnancy Failure

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This study compares different treatment methods for early missed abortion (when a pregnancy ends but the tissue doesn't pass on its own) to see which works best in real-world settings. It may help you and your doctor choose the safest and most effective option.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
580 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You are 18 to 40 years old.
  • You have been diagnosed with an early missed abortion (the pregnancy stopped growing but hasn't passed).
  • Your routine blood tests and health checks are normal, and you don't have serious diseases like heart, liver, or kidney problems.
  • You are not currently having heavy vaginal bleeding that needs emergency treatment.
  • You are willing to come back for checkups as planned.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07526064Not yet recruiting· Phase 1
Oral vs. Vaginal Medicine for Miscarriage Management

This study compares two ways of taking medicine (by mouth or vaginal insertion) to safely manage a miscarriage that was discovered on ultrasound between 8–16 weeks of pregnancy. The goal is to see which method works better and causes fewer side effects.

Islamabad
NCT06546397Recruiting· Phase 1
Hormone therapy for uterine healing after abortion

This trial tests if taking estrogen and progesterone after an induced abortion helps the uterus heal better. It may reduce complications and support recovery.

Hangzhou, Zhejiang
NCT07767435Not yet recruiting· Phase 1/Phase 2
Comparing two medications for second-trimester abortion

This study compares two medications—letrozole plus misoprostol versus misoprostol alone—to see which is more effective for ending a pregnancy in the second trimester (14–20 weeks) after the fetus has stopped developing. The goal is to find a safer, more comfortable method for women who need this procedure.

NCT07381569Not yet recruiting
Studying a new estrogen device for safer abortion recovery

This trial tests a new intrauterine device that slowly releases estrogen to help the uterus recover after an induced abortion. It may be an option for women who have had multiple abortions or a missed abortion.

Beijing, Dongcheng
NCT04183829Recruiting
Study of effects after early induced abortion

This study looks at pregnancy complications and outcomes after someone has an induced abortion in early pregnancy. It may help doctors better understand what to watch for in future pregnancies and how to reduce risks.

Zhongshan, Guangdong
NCT06502158Recruiting· Phase 1
Comparing two medications for second-trimester abortion

This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.

The Bronx, New York

Hear when a new Missed Abortion trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.